Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fania Szlam

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 16, 2014
Effects of a plasma-derived C1 esterase inhibitor on hemostatic activation, clot formation, and thrombin generationJerrold H Levy, Fania Szlam, Steven Gelone
British Journal of Haematology|June 29, 2006
The effect of aprotinin on activated protein C-mediated downregulation of endogenous thrombin generationKenichi A Tanaka, Fania Szlam, Jerrold H Levy
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 22, 2006
Tissue plasminogen activator and thrombin generation measurements using the ThrombinoscopeFania Szlam, Jerrold H Levy, Kenichi A Tanaka
Anesthesia and Analgesia|May 28, 2005
The effects of platelet count on clot retraction and tissue plasminogen activator-induced fibrinolysis on thrombelastographyNobuyuki Katori, Kenichi A Tanaka, Fania Szlam, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 9, 2008
Warfarin reversal with prothrombin complex concentrate confers better antifibrinolytic activity compared with recombinant activated factor VIITaro Taketomi, Fania Szlam, Jerrold H Levy, et al.
Journal of Cardiothoracic and Vascular Anesthesia|January 9, 2010
Argatroban "reversal" is caused by nonphysiologic stimulation of coagulation, not activated factor VIIKenichi A Tanaka, Fania Szlam, Kaoru Koyama, et al.
Thrombosis Research|November 6, 2007
Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulationKenichi A Tanaka, Fania Szlam, Gerhard Dickneite, et al.
Clinics in Laboratory Medicine|August 30, 2014
Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testingJerrold H Levy, Fania Szlam, Alisa S Wolberg, et al.
Anesthesia and Analgesia|November 25, 2004
A novel method to assess platelet inhibition by eptifibatide with thrombelastographNobuyuki Katori, Fania Szlam, Jerrold H Levy, et al.
Journal of Thrombosis and Haemostasis : JTH|September 16, 2022
COVID-19 patient fibrinogen produces dense clots with altered polymerization kinetics, partially explained by increased sialic acidNina Moiseiwitsch, Nicole Zwennes, Fania Szlam, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 16, 2014
Effects of a plasma-derived C1 esterase inhibitor on hemostatic activation, clot formation, and thrombin generationJerrold H Levy, Fania Szlam, Steven Gelone
British Journal of Haematology|June 29, 2006
The effect of aprotinin on activated protein C-mediated downregulation of endogenous thrombin generationKenichi A Tanaka, Fania Szlam, Jerrold H Levy
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 22, 2006
Tissue plasminogen activator and thrombin generation measurements using the ThrombinoscopeFania Szlam, Jerrold H Levy, Kenichi A Tanaka
Anesthesia and Analgesia|May 28, 2005
The effects of platelet count on clot retraction and tissue plasminogen activator-induced fibrinolysis on thrombelastographyNobuyuki Katori, Kenichi A Tanaka, Fania Szlam, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 9, 2008
Warfarin reversal with prothrombin complex concentrate confers better antifibrinolytic activity compared with recombinant activated factor VIITaro Taketomi, Fania Szlam, Jerrold H Levy, et al.
Journal of Cardiothoracic and Vascular Anesthesia|January 9, 2010
Argatroban "reversal" is caused by nonphysiologic stimulation of coagulation, not activated factor VIIKenichi A Tanaka, Fania Szlam, Kaoru Koyama, et al.
Thrombosis Research|November 6, 2007
Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulationKenichi A Tanaka, Fania Szlam, Gerhard Dickneite, et al.
Clinics in Laboratory Medicine|August 30, 2014
Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testingJerrold H Levy, Fania Szlam, Alisa S Wolberg, et al.
Anesthesia and Analgesia|November 25, 2004
A novel method to assess platelet inhibition by eptifibatide with thrombelastographNobuyuki Katori, Fania Szlam, Jerrold H Levy, et al.
Journal of Thrombosis and Haemostasis : JTH|September 16, 2022
COVID-19 patient fibrinogen produces dense clots with altered polymerization kinetics, partially explained by increased sialic acidNina Moiseiwitsch, Nicole Zwennes, Fania Szlam, et al.
Pageof 7